Ticaplat (Ticagrelor) Tablet

Description

Description

This page contains brief details about the drug ticagrelor, it’s indication, dosage & administaration, mechanism of action, related brands with strength, warnings and common side effects.

Date of Approval

Ticagrelor is an antiplatelet medication developed by the U.S. Food And Drug Administration and initially approved on 20 July 2011, for treating acute coronary syndrome (ACS).

Mechanism of Action of Ticagrelor

Ticagrelor works by inhibiting platelet activation and aggregation. It specifically blocks a receptor called P2Y12 on the platelets, preventing them from clumping together and forming blood clots. This helps reduce the risk of heart-related events in individuals with ACS.

Uses of Ticagrelor

Ticagrelor is used to prevent blood clots in patients with acute coronary syndrome (ACS), including unstable angina or myocardial infarction (heart attack).

Ticagrelor Dosage available

Ticagrelor is a prescription medicine available as a tablet in two doses, Ticagrelor 60mg and Ticagrelor 90mg. Do not crush, chew, or open the medicine. Your physician will decide the correct dosage and duration based on age, body weight, and disease condition. Only stop taking the tablet if your doctor advises you to stop.